An open-label, multicenter, randomized study Evaluating the efficacy and safety of glofitamab In combination with gemcitabine plus oxaliplatin Versus standard of care in patients with Relapsed/refractory large b-cell lymphoma (ChiCTR) - Oct 16, 2026 - P4 | N=96 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University
New P4 trial • B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|